— Onconova Therapeutics (NASDAQ: ONTX) reported FY2019 net loss of $1.49 per share, vs. $4.99 per share last year.
— Net loss was $21.5 million compared to $20.4 million last year.
— Research and development expenses were $15.5 million versus $16.9 million for 2018.
— Cash and cash equivalents as of December 31, 2019, totaled $22.7 million, compared to $17 million as of December 31, 2018.
Citrix Systems, Inc. (NASDAQ: CTXS) stock retreated on Tuesday due to concerns about its growth after reaching a record high of $146.25 on Monday. The digital workspace platform turned beneficial
BlackBerry Limited (NYSE: BB) reported fourth-quarter 2020 earnings results on Tuesday, March 31, after the market close. BB stock gained about 2% during after-market hours following the announcement. BlackBerry stock,
Carnival Corporation’s (NYSE: CCL) shares were up over 6% in afternoon trade on Tuesday. The stock has dropped 73% since the beginning of this year. The travel industry has been